These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2516947)

  • 1. [The epidemiological characteristics of meningococcal infection in the USSR].
    Deviatkin NP; Demina AA; Pichushkov AV
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Dec; (12):36-40. PubMed ID: 2516947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of bacterial vaccines for prevention of pneumococcal and meningococcal disease in the day care setting.
    Broome CV
    Rev Infect Dis; 1986; 8(4):584-8. PubMed ID: 3092300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An animal model for testing the activity of meningococcal polysaccharide vaccine].
    Huet M; Suire A
    J Biol Stand; 1981 Jan; 9(1):67-74. PubMed ID: 6783665
    [No Abstract]   [Full Text] [Related]  

  • 4. Group-specific meningococcal vaccination and epidemics caused by other groups of meningococci.
    Mäkelä PH; Peltola H
    Lancet; 1978 Oct; 2(8093):780-1. PubMed ID: 80699
    [No Abstract]   [Full Text] [Related]  

  • 5. [Epidemiological characteristics of meningococcal infection in Cuba].
    Terry Molinert G; Demina AA; Valcarcel Novo M
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Feb; (2):54-9. PubMed ID: 3083621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology and control of invasive meningococcal disease.
    Diaz PS
    Pediatr Infect Dis J; 1999 Jul; 18(7):633-4. PubMed ID: 10440442
    [No Abstract]   [Full Text] [Related]  

  • 7. [An analysis of the epidemic cycle of meningococcal infection in Russia (1969-1993)].
    Demina AA; Martynov IuV
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (4):57-61. PubMed ID: 9027178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A field trial with the liquid multicomponent meningococcal vaccine ABC].
    Levina LA; Filippov IuV; Vartanian IuP; Ratiner IuA; Salov VF
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Nov; (11):62-4. PubMed ID: 3146194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
    Noronha CP; Struchiner CJ; Halloran ME
    Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel quadrivalent meningococcal A, C, W-135 and Y glycoconjugate vaccine for the broader protection of adolescents and adults.
    Pace D
    Future Microbiol; 2010 Nov; 5(11):1629-40. PubMed ID: 21133685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.
    Hill DM; Lucidarme J; Gray SJ; Newbold LS; Ure R; Brehony C; Harrison OB; Bray JE; Jolley KA; Bratcher HB; Parkhill J; Tang CM; Borrow R; Maiden MC
    Lancet Infect Dis; 2015 Dec; 15(12):1420-8. PubMed ID: 26515523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges for development of meningococcal vaccines in infants and children.
    Deasy A; Read RC
    Expert Rev Vaccines; 2011 Mar; 10(3):335-43. PubMed ID: 21434801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the effectiveness of targeted vaccination with the meningococcal polysaccharide A and C vaccine in one location in the Czech Republic].
    Krízová P; Vlcková J; Bobák M
    Epidemiol Mikrobiol Imunol; 1995 Mar; 44(1):9-14. PubMed ID: 7757351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardisation and validation of serological assays for the evaluation of immune responses to Neisseria meningitidis serogroup A and C vaccines.
    Jodar L; Cartwright K; Feavers IM
    Biologicals; 2000 Sep; 28(3):193-7. PubMed ID: 10964447
    [No Abstract]   [Full Text] [Related]  

  • 15. Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37.
    Krizova P; Musilek M
    Cent Eur J Public Health; 1995 Nov; 3(4):189-94. PubMed ID: 8903519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role and place of serologic research in the system of epidemiologic surveillance of meningococcal infection].
    Kostiukova NN; Tumanian AA; Babich EM; Tatarnikov VM; Sipacheva NB
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Nov; (11):36-41. PubMed ID: 3146192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Haemophilus influenzae type b invasive disease and meningococcal disease: incidence and characteristics in Barcelona, 1994-1995. Work Group IMS-IUSPC for Surveillance and Control of Meningitis].
    Beni C; Caylà JA; Jansà JM; Maldonado R; Pañella H; Rajmil L; Villalbí JR
    Med Clin (Barc); 1999 Jan; 112(1):1-4. PubMed ID: 10027177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningococcal disease: the advances and challenges of meningococcal disease prevention.
    Yogev R; Tan T
    Hum Vaccin; 2011 Aug; 7(8):828-37. PubMed ID: 21832882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Criteria of the epidemiological surveillance of meningococcal infection].
    Deviatkina NP; Demina AA; Larina LI; Akinshina TM; Babich EM
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Aug; (8):75-8. PubMed ID: 6817566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects for the prevention of meningococcal disease: special reference to group B.
    Frasch CE
    Vaccine; 1987 Mar; 5(1):3-4. PubMed ID: 3107234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.